Zubler R H
J Immunol. 1981 Feb;126(2):557-62.
Antibody formed during a 1st in vitro anti-SRBC PFC response had previously been shown to inhibit the formation of PFC when added to a 2nd, freshly established test culture. This effect was to a large extent restricted to test cultures containing B cells sharing VH genes with the B cells producing the initial antibody, and this suggested that anti-SRBC antibody acted via triggering of an anti-idiotypic antibody of TS response. In the present studies this system has been further characterized. First, such antibody feedback occurred in cultures of purified and anti-Lyt2 antiserum and complement-treated surface Ig-positive cells in which TH were substituted for by T-replacing factor. Thus, T cells were not required. Moreover, T cells were always nonspecifically activated in cultures containing FCS. Secondly, anti-idiotypic antibody-like activity was not detected in the sense that generation of inhibitory antibody was never found to be dissociated from generation of anti-SRBC antibody, and LPS-dependent anti-SRBC PFC responses were not inhibited. However, feedback inhibition of SRBC-dependent responses was reversed at increased SRBC concentrations. Thirdly, the feedback mechanism was highly epitope specific, whereas in vitro anti-SRBC PFC responses of different mouse strains (B6 vs BALB/c) were directed to a large extent against different epitopes. These data strongly suggest that VH-restricted inhibitory activity of antibody in this system is a manifestation of epitope specificity of the antibody feedback and not of idiotype specificity, i.e., that anti-SRBC antibody acts via masking of epitopes.
在首次体外抗绵羊红细胞(SRBC)空斑形成细胞(PFC)反应中形成的抗体,先前已证明,当将其添加到第二个新建立的测试培养物中时,会抑制PFC的形成。这种效应在很大程度上仅限于含有与产生初始抗体的B细胞共享VH基因的B细胞的测试培养物,这表明抗SRBC抗体通过触发TS反应的抗独特型抗体起作用。在本研究中,该系统已得到进一步表征。首先,这种抗体反馈发生在纯化的、用抗Lyt2抗血清和补体处理的表面Ig阳性细胞的培养物中,其中TH被T替代因子取代。因此,不需要T细胞。此外,在含有胎牛血清(FCS)的培养物中,T细胞总是被非特异性激活。其次,未检测到抗独特型抗体样活性,因为从未发现抑制性抗体的产生与抗SRBC抗体的产生解离,并且脂多糖(LPS)依赖性抗SRBC PFC反应未受到抑制。然而,在SRBC浓度增加时,SRBC依赖性反应的反馈抑制被逆转。第三,反馈机制具有高度表位特异性,而不同小鼠品系(B6与BALB/c)的体外抗SRBC PFC反应在很大程度上针对不同的表位。这些数据强烈表明,该系统中抗体的VH限制抑制活性是抗体反馈表位特异性的表现,而不是独特型特异性的表现,即抗SRBC抗体通过掩盖表位起作用。